Cargando…
The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice
To inform clinical guidelines and patient care we need high quality evidence on the relative benefits and harms of intervention. Patient reported outcome (PRO) data from clinical trials can “empower patients to make decisions based on their values” and “level the playing field between physician and...
Autores principales: | Calvert, Melanie, Brundage, Michael, Jacobsen, Paul B, Schünemann, Holger J, Efficace, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842645/ https://www.ncbi.nlm.nih.gov/pubmed/24168680 http://dx.doi.org/10.1186/1477-7525-11-184 |
Ejemplares similares
-
Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2022) -
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
por: Liu, Xiaoxuan, et al.
Publicado: (2020) -
Improving the reporting of pragmatic trials: an extension of the CONSORT statement
por: Zwarenstein, Merrick, et al.
Publicado: (2008) -
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
por: Yap, Christina, et al.
Publicado: (2023) -
Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol
por: Ahmed, Khaled, et al.
Publicado: (2016)